cupric nitrilotriacetate has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackland, ML; Alvarez, A; Grana, A; Hamer, P; Ho, YH; Jamil, R; Kim, S; Linder, MC; Mercer, JF; Michalczyk, A; Moriya, M; Nguyen, L; Ramos, D | 1 |
| Athar, M; Giri, U; Iqbal, M | 1 |
2 other study(ies) available for cupric nitrilotriacetate and Liver Neoplasms
| Article | Year |
|---|---|
Copper is taken up efficiently from albumin and alpha2-macroglobulin by cultured human cells by more than one mechanism.
Topics: alpha-Macroglobulins; Binding, Competitive; Breast Neoplasms; Cation Transport Proteins; Cell Line, Tumor; Copper; Copper Transporter 1; Female; Histidine; Humans; Ion Transport; Iron; Kinetics; Liver Neoplasms; Manganese; Nitrilotriacetic Acid; Organometallic Compounds; Protein Binding; Serum Albumin; Silver; Zinc | 2008 |
Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.
Topics: Animals; Carcinogens; Cell Division; Diethylnitrosamine; Kidney Neoplasms; Liver Neoplasms; Male; Mice; Nitrilotriacetic Acid; Organometallic Compounds | 1999 |